CognitiveImmune
Selank
Heptapeptide · Tuftsin analogue · 7 amino acids
FDA · NOT REVIEWED (RUSSIAN RESEARCH)
Half-life
~4 minutes
Very short
minsdays
Route
SubQ injection
Evidence
Approved therapeutic
Risk
Standard
Overview
Known for
Mechanism
Key facts
Format
Lyophilized powder
Mechanism targets
Classification
Authoritative
Supply & nature
ExogenousExogenous
FDA category
Not reviewed (Russian research)
Evidence & standing
Evidence base
Approved therapeutic
Risk level
Standard
Best studies
5 references
Dosage & protocol
Typical dose
200-400mcg
Research range
250–500 µg
Cycle
2 weeks on / 2 weeks off
Onset
0 days first effects
Full effect
21 days
Half-life
~3-5min
~3-5 minutes (intranasal — acts rapidly on brain)
Protocol
Time to effects
Recommended vial
Reference figures only
Dosing reflects published laboratory protocols and is not guidance for use in any living subject.
Safety
Reversibility
Fully Reversible
Side effects
Interactions
Handle with research caution
Storage & handling
Lyophilised
12–24 months
room temp
Reconstituted
2–4 weeks
2–8°C
Videos & talks
Independent educational content from researchers, clinicians and science communicators — not affiliated with Pepnerd.
Educational resources only. Videos are independent third-party content. Pepnerd is not affiliated with these creators and does not endorse or make claims based on their content. All products are for in-vitro research.